Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 12, 2013, Pages 1555-1561

  Yilmaz, O ^a   Ertoy Karagol, I H ^a   Bakirtas, A ^a   Topal, E ^a   Celik, G E ^b   Demirsoy, M S ^a   Turktas, I ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

drug allergy; pediatrics

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRONE; IBUPROFEN; KETOPROFEN; MELOXICAM; METAMIZOLE SODIUM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TOLMETIN; UNCLASSIFIED DRUG;

ADOLESCENT; ALGORITHM; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FACE DISORDER; FAMILY HISTORY; FEMALE; FINGER EDEMA; FOREHEAD EDEMA; HAND DISEASE; HAND EDEMA; HUMAN; IMMUNE FUNCTION TEST; INFANT; INTRACUTANEOUS TEST; LIP DISEASE; LIP EDEMA; MAJOR CLINICAL STUDY; MALE; ORAL PROVOCATION TEST; PATIENT SAFETY; PERIORBITAL EDEMA; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; SCHOOL CHILD; SKIN PRICK TEST; URTICARIA;

DRUG ALLERGY; PEDIATRICS;

ADOLESCENT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHIAL PROVOCATION TESTS; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INFANT; MALE; PROGNOSIS; SKIN TESTS;

EID: 84889605317     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12266     Document Type: Article

References (20)

1. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al. Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
2. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphanazone. J Allergy Clin Immunol 2003; 111: 882-888.
3. Kowalski ML, Stevenson DD,. Classification of reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2013; 33: 135-145.
4. Demoly P, Kropf R, Bircher A, Pichler WJ,. Drug hypersensitivity: questionnaire. EAACI interestgroup on drug hypersensitivity. Allergy 1999; 54: 999-1003.
5. Rutkowski K, Nasser SM, Ewan PW,. Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol 2012; 159: 60-64.
6. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Allergy 2003; 58: 854-863.
7. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P,. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
8. Doña I, Blanca-Lõpez N, Cornejo-García JA, Torres MJ, Laguna JJ, Fernández J, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41: 86-95.
9. Schubert B, GrossePerdekamp MT, Pfeuffer P, Raith P, Bröcker EB, Trautmann A,. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality ? Eur J Dermatol 2005; 15: 164-167.
10. Uetrecht JP,. New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem ResToxicol 1999; 12: 387-395.
11. Zambonino MA, Torres MJ, Muñoz C, Requena G, Mayorga C, Posadas T, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013; 24: 151-159.
12. Defrance C, Bousquet PJ, Demoly P,. Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs. Allergy 2011; 66: 1410-1414.
13. Sánchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F,. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol 2004; 15: 376-380.
14. Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P,. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol 2008; 18: 561-565.
15. Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to non-steroidal anti-inflammatory drugs among young, Asian, atopic children. Pediatrics 2005; 116: e675-e680.
16. Kidon MI, Liew WK, Chiang WC, Lim SH, Goh A, Tang JP, et al. Hypersensitivity to paracetamol in Asian children with early onset of non-steroidal anti-inflammatory drug allergy. Int Arch Allergy Immunol 2007; 144: 51-56.
17. Celik GE, Erkekol FO, Aydbox drawings light down and leftn O, Demirel YS, Mbox drawings light down and leftsbox drawings light down and leftrlbox drawings light down and leftgil Z,. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity? Allergol Immunopathol (Madr) 2013; 41: 181-188.
18. Domingo MV, Marchuet MJ, Culla MT, Joanpere RS, Guadaño EM,. Meloxicam tolerance in hypersensitivity to non-steroidal anti-inflammatory drugs. J Investig Allergol Clin Immunol 2006; 16: 364-366.
19. Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z,. Safety of selective COX-2 inhibitors in aspirin/non-steroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. J Asthma 2004; 41: 67-75.
20. Yilmaz O, Ertoy Karagol IH, Topal E, Demirsoy MS, Turktas I, Bakirtas A,. Tolmetin: an option for multiple NSAID hypersensitivity in a preschooler. Pediatr Allergy Immunol Pulmonol 2013; 26: 164-165.